309 related articles for article (PubMed ID: 25164769)
1. Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.
Impellizzeri D; Bruschetta G; Cordaro M; Crupi R; Siracusa R; Esposito E; Cuzzocrea S
J Neuroinflammation; 2014 Aug; 11():136. PubMed ID: 25164769
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
Ardizzone A; Fusco R; Casili G; Lanza M; Impellizzeri D; Esposito E; Cuzzocrea S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671213
[TBL] [Abstract][Full Text] [Related]
3. A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation.
Esposito E; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Gugliandolo E; Crupi R; Cuzzocrea S
Eur J Pharmacol; 2016 Jul; 782():107-18. PubMed ID: 27095683
[TBL] [Abstract][Full Text] [Related]
4. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
[TBL] [Abstract][Full Text] [Related]
5. Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect.
Petrosino S; Cordaro M; Verde R; Schiano Moriello A; Marcolongo G; Schievano C; Siracusa R; Piscitelli F; Peritore AF; Crupi R; Impellizzeri D; Esposito E; Cuzzocrea S; Di Marzo V
Front Pharmacol; 2018; 9():249. PubMed ID: 29615912
[TBL] [Abstract][Full Text] [Related]
6. The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats.
Siracusa R; Fusco R; Cordaro M; Peritore AF; D'Amico R; Gugliandolo E; Crupi R; Genovese T; Evangelista M; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080989
[TBL] [Abstract][Full Text] [Related]
7. 2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation.
Impellizzeri D; Cordaro M; Bruschetta G; Crupi R; Pascali J; Alfonsi D; Marcolongo G; Cuzzocrea S
Pharmacol Res; 2016 Jun; 108():23-30. PubMed ID: 27083308
[TBL] [Abstract][Full Text] [Related]
8. Ultramicronized N-palmitoylethanolamine associated with analgesics: Effects against persistent pain.
Nobili S; Micheli L; Lucarini E; Toti A; Ghelardini C; Di Cesare Mannelli L
Pharmacol Ther; 2024 Jun; 258():108649. PubMed ID: 38615798
[TBL] [Abstract][Full Text] [Related]
9. Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.
Fusco R; Gugliandolo E; Campolo M; Evangelista M; Di Paola R; Cuzzocrea S
PLoS One; 2017; 12(6):e0178553. PubMed ID: 28594885
[TBL] [Abstract][Full Text] [Related]
10. Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.
D'Amico R; Monaco F; Siracusa R; Cordaro M; Fusco R; Peritore AF; Gugliandolo E; Crupi R; Cuzzocrea S; Di Paola R; Impellizzeri D; Genovese T
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768820
[TBL] [Abstract][Full Text] [Related]
11. Micronized palmitoylethanolamide reduces joint pain and glial cell activation.
Bartolucci ML; Marini I; Bortolotti F; Impellizzeri D; Di Paola R; Bruschetta G; Crupi R; Portelli M; Militi A; Oteri G; Esposito E; Cuzzocrea S
Inflamm Res; 2018 Oct; 67(10):891-901. PubMed ID: 30121836
[TBL] [Abstract][Full Text] [Related]
12. Effect of cannabidiolic acid and ∆
Rock EM; Limebeer CL; Parker LA
Psychopharmacology (Berl); 2018 Nov; 235(11):3259-3271. PubMed ID: 30225659
[TBL] [Abstract][Full Text] [Related]
13. Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells.
Iuvone T; Affaitati G; De Filippis D; Lopopolo M; Grassia G; Lapenna D; Negro L; Costantini R; Vaia M; Cipollone F; Ialenti A; Giamberardino MA
Pain; 2016 Jan; 157(1):80-91. PubMed ID: 25974242
[TBL] [Abstract][Full Text] [Related]
14. Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.
Petrosino S; Ahmad A; Marcolongo G; Esposito E; Allarà M; Verde R; Cuzzocrea S; Di Marzo V
Pharmacol Res; 2015 Jan; 91():9-14. PubMed ID: 25447594
[TBL] [Abstract][Full Text] [Related]
15. Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial.
Andresen SR; Bing J; Hansen RM; Biering-Sørensen F; Johannesen IL; Hagen EM; Rice ASC; Nielsen JF; Bach FW; Finnerup NB
Pain; 2016 Sep; 157(9):2097-2103. PubMed ID: 27227691
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain.
Cordaro M; Siracusa R; Impellizzeri D; D' Amico R; Peritore AF; Crupi R; Gugliandolo E; Fusco R; Di Paola R; Schievano C; Cuzzocrea S
Arthritis Res Ther; 2019 Nov; 21(1):254. PubMed ID: 31779692
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective effects of micronized PEA (PEA-m) formulation on diabetic peripheral neuropathy in mice.
Impellizzeri D; Peritore AF; Cordaro M; Gugliandolo E; Siracusa R; Crupi R; D'Amico R; Fusco R; Evangelista M; Cuzzocrea S; Di Paola R
FASEB J; 2019 Oct; 33(10):11364-11380. PubMed ID: 31344333
[TBL] [Abstract][Full Text] [Related]
18. Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Orefice NS; Alhouayek M; Carotenuto A; Montella S; Barbato F; Comelli A; Calignano A; Muccioli GG; Orefice G
Neurotherapeutics; 2016 Apr; 13(2):428-38. PubMed ID: 26857391
[TBL] [Abstract][Full Text] [Related]
19. Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO.
Di Paola R; Cordaro M; Crupi R; Siracusa R; Campolo M; Bruschetta G; Fusco R; Pugliatti P; Esposito E; Cuzzocrea S
Shock; 2016 Aug; 46(2):202-13. PubMed ID: 26844976
[TBL] [Abstract][Full Text] [Related]
20. Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat.
Peritore AF; Siracusa R; Fusco R; Gugliandolo E; D'Amico R; Cordaro M; Crupi R; Genovese T; Impellizzeri D; Cuzzocrea S; Di Paola R
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
